subject: UNII:6ZA31Y954Z

object_name: testicular cancer


subject: UNII:6ZA31Y954Z

subject_name: Brodalumab

object_name: carcinoma of esophagus

tested_intervention: yes


subject: UNII:6ZA31Y954Z

object_name: esophageal cancer


subject: UNII:6ZA31Y954Z

object_name: Childhood Esophageal Carcinoma


subject: UNII:6ZA31Y954Z

object_name: neoplasm of esophagus


subject: UNII:6ZA31Y954Z

object_name: female reproductive organ cancer


subject: UNII:6ZA31Y954Z

object_name: brain neoplasm


subject: UNII:6ZA31Y954Z

object_name: Childhood Solid Neoplasm


subject: UNII:6ZA31Y954Z

object_name: Adult Solid Neoplasm


subject: UNII:6ZA31Y954Z

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:9874151

subject_name: Angeliq

object_name: vasomotor symptom

tested_intervention: unsure


subject: UMLS:C1455162


subject: CHEBI:50838

subject_name: Drospirenone


subject: UMLS:C5206815

object_name: neoplastic meningitis


subject: UMLS:C5206815


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: Heart Failure, CTCAE


subject: CHEBI:15552

subject_name: Epoprostenol

object_name: heart failure


subject: CHEBI:15552


subject: PUBCHEM.COMPOUND:138566969

subject_name: Baloxavir marboxil

object_name: viral respiratory tract infection


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: combined hepatocellular carcinoma and cholangiocarcinoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UNII:GKF8S4C432

subject_name: Anlotinib


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:23066

subject_name: cephalosporin

object_name: Community-Acquired Pneumonia


subject: CHEBI:25105

subject_name: macrolide antibiotic


subject: UMLS:C0003240

subject_name: Macrolide Antibiotics


subject: UNII:2BT4C47RUI

subject_name: Necitumumab

object_name: Refractory Lung Non-Small Cell Carcinoma


subject: UNII:2BT4C47RUI

object_name: Stage IVA Lung Cancer AJCC v8


subject: UNII:2BT4C47RUI

object_name: Stage IVB Lung Cancer AJCC v8


subject: UNII:2BT4C47RUI

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:90943

subject_name: Osimertinib


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: Venous collateral circulation


subject: UMLS:C0678113

subject_name: Actilyse


subject: UMLS:C2266918

subject_name: Platinum-based Drug [EPC]

object_name: esophageal cancer


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Cerebral metastasis


subject: UNII:2S9ZZM9Q9V

object_name: adenocarcinoma of lung metastatic to brain


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: UMLS:C3896750

object_name: rheumatoid arthritis


subject: UMLS:C5554903

subject_name: Docetaxel-TH19P01 Conjugate TH1902

object_name: prostate carcinoma


subject: UMLS:C5554903

object_name: prostate cancer


subject: UMLS:C5554903

object_name: thyroid tumor


subject: UMLS:C5554903

object_name: thyroid gland carcinoma


subject: UMLS:C5554903

object_name: thyroid cancer


subject: UMLS:C5554903

object_name: Childhood Solid Neoplasm


subject: UMLS:C5554903

object_name: Adult Solid Neoplasm


subject: UMLS:C5554903

object_name: Solid Neoplasm


subject: UMLS:C5554903

object_name: ovarian carcinoma


subject: UMLS:C5554903

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5554903

object_name: melanoma


subject: UMLS:C5554903

object_name: skin melanoma


subject: UMLS:C5554903

object_name: endometrial cancer


subject: UMLS:C5554903

object_name: uterine corpus cancer


subject: UMLS:C5554903

object_name: endometrial carcinoma


subject: UMLS:C5554903

object_name: hormone receptor-positive breast cancer


subject: UMLS:C5554903

object_name: triple-negative breast carcinoma


subject: MESH:C000591995


subject: MESH:C000591995


subject: MESH:C000591995


subject: MESH:C000591995

object_name: cancer


subject: MESH:C000591995

object_name: neoplasm


subject: UMLS:C2703116


subject: UMLS:C2703116


subject: UMLS:C2703116


subject: UMLS:C2703116


subject: UMLS:C2703116


subject: CHEBI:38215

subject_name: calcium channel blocker

object_name: atrial fibrillation


subject: CHEBI:38215

object_name: Heart failure with normal ejection fraction


subject: UMLS:C0006684

subject_name: Calcium Channel Blockers


subject: UMLS:C0006684


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:3223

subject_name: Buspirone

object_name: hypoactive sexual desire disorder


subject: CHEBI:77655

subject_name: perindopril arginine

object_name: Marfan syndrome


subject: UMLS:C0678178

subject_name: Coversyl


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: multiple organ dysfunction syndrome


subject: UMLS:C4086992

subject_name: Albis

object_name: Peptic Ulcer


subject: UMLS:C4086992

object_name: gastritis


subject: UMLS:C4086992

object_name: Gastritis, CTCAE


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Childhood Neuroblastoma


subject: CHEBI:201431

object_name: neuroblastoma


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: UMLS:C4733271

subject_name: SB injection

object_name: non-small cell lung carcinoma


subject: CHEBI:9241

subject_name: Spironolactone

object_name: type 1 diabetes mellitus


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: Physical trauma


subject: UMLS:C5203530

object_name: Injury


subject: UMLS:C5203530

object_name: Trauma


subject: UMLS:C5203530

object_name: Fractured lower leg


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:94518


subject: CHEBI:94518


subject: CHEBI:94518


subject: CHEBI:231350

subject_name: Pacritinib

object_name: colorectal cancer


subject: CHEBI:231350

object_name: colorectal carcinoma


subject: CHEBI:231350

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:9940097

subject_name: Hyzaar

object_name: abdominal obesity-metabolic syndrome


subject: PUBCHEM.COMPOUND:9940097

object_name: metabolic syndrome X


subject: PUBCHEM.COMPOUND:9940097

object_name: hypertension


subject: PUBCHEM.COMPOUND:9940097

object_name: Hypertension, CTCAE


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:149504


subject: CHEBI:149504


subject: CHEBI:9649

subject_name: Trandolapril


subject: CHEBI:9649


subject: CHEBI:77733

subject_name: Verapamil


subject: CHEBI:77733


subject: UMLS:C3714111

object_name: Childhood Solid Neoplasm


subject: UMLS:C3714111

object_name: Adult Solid Neoplasm


subject: UMLS:C3714111

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:129234005

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:129234005

object_name: lymphoma, non-Hodgkin, familial


subject: PUBCHEM.COMPOUND:129234005

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:129234005

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:129234005

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:129234005


subject: PUBCHEM.COMPOUND:129234005

object_name: neoplasm


subject: UNII:Y8U0XA0OJE


subject: UNII:Y8U0XA0OJE


subject: UNII:Y8U0XA0OJE


subject: UNII:Y8U0XA0OJE


subject: UNII:Y8U0XA0OJE


subject: UNII:Y8U0XA0OJE


subject: UNII:Y8U0XA0OJE


subject: UNII:N8VKI8FPW0


subject: UNII:N8VKI8FPW0


subject: PUBCHEM.COMPOUND:155925839


subject: PUBCHEM.COMPOUND:155925839


subject: PUBCHEM.COMPOUND:155925839


subject: PUBCHEM.COMPOUND:155925839


subject: UMLS:C5204981

subject_name: MALT1 Inhibitor JNJ-67856633


subject: UMLS:C5204981


subject: UMLS:C5204981


subject: UMLS:C5204981


subject: UMLS:C5556844

subject_name: Anti-TMEFF2/Anti-CD3 Bispecific Antibody JNJ-70218902


subject: UMLS:C5556844


subject: UMLS:C5556844


subject: UMLS:C5556844


subject: UMLS:C5556844


subject: UMLS:C5556844


subject: UMLS:C5555047

subject_name: DHODH Inhibitor JNJ-74856665


subject: UMLS:C5555047


subject: UMLS:C5555047


subject: UMLS:C5555047


subject: UMLS:C5555047


subject: UMLS:C5555015

subject_name: Rezetamig


subject: UMLS:C5555015


subject: UMLS:C5555015


subject: UMLS:C5555015


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:6078

subject_name: Ivermectin


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:94807

subject_name: Nitazoxanide


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: CHEBI:63453

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:63453

object_name: squamous cell lung carcinoma


subject: CHEBI:95093

subject_name: Omipalisib

object_name: interstitial lung disease 1


subject: CHEBI:95093

object_name: interstitial lung disease 2


subject: UMLS:C2981793


subject: UMLS:C2981793


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Advanced Sarcoma


subject: CHEBI:233362

object_name: Advanced Pancreatic Carcinoma


subject: CHEBI:233362

object_name: Advanced Prostate Carcinoma


subject: CHEBI:233362

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:233362

object_name: Advanced Breast Carcinoma


subject: CHEBI:233362

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:233362

object_name: Advanced Ovarian Carcinoma


subject: CHEBI:233362

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:233362

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:4953

subject_name: Exemestane


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:4953

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:4953

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:91951


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:49668

subject_name: Gefitinib


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:49668


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:90943

subject_name: Osimertinib


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:90943

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:90943


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: Chemotherapy-induced nausea and vomiting


subject: CHEBI:8499

subject_name: Propranolol

object_name: esophageal adenocarcinoma


subject: UMLS:C5237425

subject_name: STING Agonist GSK3745417

object_name: acute myeloid leukemia


subject: UMLS:C1136254

subject_name: Microbicides

object_name: Prosthetic joint infection


subject: UMLS:C5399717

subject_name: Antimicrobial [APC]


subject: UNII:AVK0I6HY2U

subject_name: Abaloparatide

object_name: intervertebral disk degenerative disorder


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: Refractory Lymphoma


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: UNII:AG9MHG098Z

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:AG9MHG098Z

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:O2Z8Q22ZE4

subject_name: Cavosonstat

object_name: cystic fibrosis


subject: UNII:F5UM2KM3W7

subject_name: BENZALKONIUM CHLORIDE

object_name: ocular hypertension


subject: UNII:F5UM2KM3W7

object_name: Ocular hypertension


subject: UNII:F5UM2KM3W7

object_name: glaucoma


subject: UNII:F5UM2KM3W7

object_name: Glaucoma, CTCAE


subject: CHEBI:135611

subject_name: Benzalkonium


subject: CHEBI:135611


subject: CHEBI:135611


subject: CHEBI:135611


subject: UNII:JWF5YAW3QW

subject_name: Valerian

object_name: Parkinson disease


subject: UNII:JWF5YAW3QW

object_name: insomnia


subject: UNII:JWF5YAW3QW

object_name: Insomnia, CTCAE 3.0


subject: UNII:JWF5YAW3QW

object_name: Insomnia, CTCAE 5.0


subject: UMLS:C3864309

subject_name: PAPILLOMAVIRUS HUMAN 9-VALENT VACCINE

object_name: common wart


subject: UNII:RC2V4W0EYC

subject_name: Buloxibutid

object_name: systemic sclerosis


subject: UNII:RC2V4W0EYC

object_name: Raynaud disease


subject: GTOPDB:7037


subject: GTOPDB:7037


subject: UNII:GK1LYB375A

subject_name: Tralokinumab

object_name: asthma


subject: PUBCHEM.COMPOUND:123610

subject_name: Eptifibatide

object_name: myocardial ischemia


subject: PUBCHEM.COMPOUND:123610

object_name: coronary atherosclerosis


subject: CHEBI:77543

subject_name: Ebselen

object_name: bipolar disorder


subject: CHEBI:77543

object_name: Manic Disorder


subject: UMLS:C2701862

subject_name: CarBAMazepine ER

object_name: Mania, CTCAE


subject: UMLS:C2701862

object_name: Mania


subject: CHEBI:3387

subject_name: Carbamazepine


subject: CHEBI:3387


subject: PR:000029261

subject_name: acylamino-acid-releasing enzyme

object_name: diabetic maculopathy


subject: UMLS:C0163401

subject_name: aryldialkylphosphatase


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: superficial urinary bladder carcinoma


subject: UNII:8YHH21923L

object_name: cannabis abuse


subject: UMLS:C5139947


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: milk allergy


subject: UNII:2P471X1Z11

object_name: Cow milk allergy


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UMLS:C3883362

subject_name: Programmed Death Receptor-1 Blocking Antibody

object_name: pancreatic neoplasm


subject: UMLS:C3883362

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3883362

object_name: malignant pancreatic neoplasm


subject: UMLS:C4085979

object_name: mucosal melanoma


subject: UMLS:C4085979

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:5339

subject_name: Sulfasalazine

object_name: alcohol abuse


subject: PUBCHEM.COMPOUND:5339

object_name: alcohol dependence


subject: CHEBI:22586

subject_name: antioxidant

object_name: peripheral vascular disease


subject: UMLS:C0003402

subject_name: Antioxidants


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: Biliary carcinoma


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: pervasive developmental disorder


subject: CHEBI:63791

object_name: autism


subject: GTOPDB:12990

subject_name: sintilimab

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: GTOPDB:12990

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4760784

subject_name: Avena Sativa (chemical)

object_name: mood (physical finding)


subject: UMLS:C4760784

object_name: Stress


subject: UMLS:C4760784

object_name: Cognitive changes


subject: UMLS:C0939905

subject_name: oats preparation


subject: UMLS:C0939905


subject: UMLS:C0939905


subject: DRUGBANK:DB14253

subject_name: Avena sativa flowering top


subject: DRUGBANK:DB14253


subject: DRUGBANK:DB14253


subject: CHEBI:141442

subject_name: Met-Asn

object_name: HIV infection


subject: CHEBI:18291

subject_name: manganese atom


subject: PR:000004926

subject_name: carbonic anhydrase 9


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: liver cirrhosis


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:47426

subject_name: Furosemide


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: EXCESS LMW-DNA


subject: GTOPDB:13876

subject_name: nipocalimab


subject: UNII:87M90CV8NC

subject_name: NIPOCALIMAB


subject: UMLS:C5417823


subject: UMLS:C5690696

subject_name: MitoQ

object_name: Childhood Breast Carcinoma


subject: UMLS:C5690696

object_name: breast carcinoma


subject: UMLS:C5690696

object_name: breast cancer


subject: UNII:K27MHH614O

subject_name: mitoquinol


subject: UNII:K27MHH614O


subject: UNII:K27MHH614O


subject: UMLS:C0111208

subject_name: CTLA-4 Antigen

object_name: Advanced Malignant Solid Neoplasm


subject: PR:000001852

subject_name: cytotoxic T-lymphocyte protein 4


subject: UMLS:C4525627


subject: UMLS:C4764320

subject_name: Bupropion HCl Extended Release

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:136013

subject_name: Levmetamfetamine

object_name: Nasal Congestion, CTCAE


subject: CHEBI:136013

object_name: Nasal congestion


subject: UMLS:C1268848

subject_name: Dextro-methamphetamine


subject: UMLS:C1268848


subject: CHEBI:6809

subject_name: Metamfetamine


subject: CHEBI:6809


subject: UMLS:C4083270

subject_name: BIBW 2992

object_name: esophageal adenocarcinoma


subject: UMLS:C4083270

object_name: lung adenocarcinoma


subject: UMLS:C4083270

object_name: cervical adenocarcinoma


subject: UMLS:C4083270

object_name: adenocarcinoma


subject: UMLS:C4083270

object_name: bile duct adenocarcinoma


subject: UMLS:C4083270

object_name: gastric adenocarcinoma


subject: CHEBI:91400

subject_name: Afatinib


subject: CHEBI:91400


subject: CHEBI:91400


subject: CHEBI:91400


subject: CHEBI:91400


subject: CHEBI:91400


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C1618891

subject_name: Injection, azacitidine, 1 mg administered


subject: GTOPDB:9758

subject_name: camrelizumab


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C3536819

subject_name: Tricyclic Antidepressant [EPC]

object_name: Melasma


subject: UMLS:C0592117

subject_name: Slow Sodium

object_name: chronic kidney disease


subject: UMLS:C0592117

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:146444831

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:146444831

object_name: inflammatory bowel disease 1


subject: UNII:X88GCV5DSA


subject: UNII:X88GCV5DSA


subject: UMLS:C4721497

subject_name: Oral Topotecan Hydrochloride

object_name: Stage IV adult soft tissue sarcoma


subject: UMLS:C4721497

object_name: Liposarcoma metastatic


subject: UMLS:C4721497

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: UMLS:C4721497

object_name: Metastatic osteosarcoma


subject: UMLS:C4721497

object_name: adult liposarcoma


subject: UMLS:C4721497

object_name: Liposarcoma recurrent


subject: UMLS:C4721497

object_name: Osteosarcoma recurrent


subject: CHEBI:71219

subject_name: Pazopanib


subject: CHEBI:71219


subject: CHEBI:36791

subject_name: Escitalopram

object_name: fibromyalgia


subject: CHEBI:36791

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: CHEBI:36791

object_name: rheumatoid arthritis


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:3723


subject: UNII:OT4AQX5MLU

object_name: Advanced Bile Duct Carcinoma


subject: UMLS:C4744995

subject_name: SHP-1 Agonist SC-43


subject: UMLS:C0445115

subject_name: Normal saline

object_name: heart valve disorder


subject: UMLS:C0445115

object_name: Valvular Heart Disease, CTCAE


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: cardiovascular disorder


subject: MESH:D012462


subject: MESH:D012462


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: chronic hepatitis B virus infection


subject: RXCUI:8375

object_name: hepatitis B


subject: CHEBI:33569

subject_name: noradrenaline

object_name: adverse effect to anesthesia


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: osteoarthritis, knee


subject: CHEBI:52745


subject: CHEBI:132922

object_name: acute mountain sickness


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: myeloproliferative neoplasm


subject: UNII:8M7YSN2KII

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Locally Advanced Thyroid Gland Carcinoma


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: CHEBI:72317

subject_name: Cabozantinib


subject: CHEBI:75045

subject_name: Dabrafenib


subject: CHEBI:75998

subject_name: Trametinib


subject: UNII:41XGO0VS1U


subject: CHEBI:195558

subject_name: Entrectinib


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: UNII:PF9462I9HX

subject_name: Larotrectinib


subject: CHEBI:85994

subject_name: Lenvatinib


subject: UNII:1WPE73O1WV

subject_name: PRALSETINIB


subject: CHEMBL.COMPOUND:CHEMBL4582651

subject_name: Pralsetinib


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:49960

subject_name: Vandetanib


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: acute promyelocytic leukemia


subject: UNII:73SM5SF3OR

subject_name: Abrocitinib

object_name: pruritus chronic


subject: UNII:73SM5SF3OR

object_name: poikiloderma with neutropenia


subject: UNII:73SM5SF3OR

object_name: prurigo nodularis


subject: UNII:73SM5SF3OR

object_name: Chronic prurigo


subject: UNII:73SM5SF3OR

object_name: Pruritus, CTCAE


subject: UNII:73SM5SF3OR

object_name: Pruritus


subject: UNII:73SM5SF3OR

object_name: skin disorder


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: Huntington disease


subject: CHEBI:127342

object_name: chorea


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: anxiety


subject: PUBCHEM.COMPOUND:57505028

object_name: anxiety disorder


subject: PUBCHEM.COMPOUND:57505028

object_name: Anxiety symptoms


subject: PUBCHEM.COMPOUND:57505028

object_name: Anxiety, CTCAE 3.0


subject: PUBCHEM.COMPOUND:57505028

object_name: Anxiety, CTCAE 5.0


subject: PUBCHEM.COMPOUND:57505028

object_name: cocaine use disorder


subject: CHEBI:25017

subject_name: leucine

object_name: Atrophy, Disuse


subject: UMLS:C1579319

subject_name: pneumococcal conjugate vaccine

object_name: plasma cell myeloma


subject: UMLS:C1579319

object_name: Febrile Neutropenia


subject: UMLS:C1579319

object_name: Febrile Neutropenia, CTCAE


subject: CHEBI:9984

subject_name: vincaleukoblastine sulfate

object_name: Hodgkin Disease


subject: CHEBI:9984

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:9984

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:3441

subject_name: Carvedilol

object_name: secondary Parkinson disease


subject: CHEBI:3441

object_name: REM sleep behavior disorder


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: alveoli, teeth; inflammation


subject: UMLS:C0885450

subject_name: Iodoformum, iodoform, Homeopathic preparation

object_name: Alveolalgia


subject: UMLS:C0885450

object_name: Impacted third molar tooth


subject: UMLS:C0885450


subject: CHEBI:37758

subject_name: Iodoform


subject: CHEBI:37758


subject: CHEBI:37758


subject: UNII:55KHL3P693

subject_name: Galcanezumab

object_name: glossopharyngeal neuralgia


subject: UNII:55KHL3P693

object_name: trigeminal neuralgia


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Tobacco user


subject: PUBCHEM.COMPOUND:54675783

object_name: Tobacco use history


subject: PUBCHEM.COMPOUND:54675783

object_name: Encounter due to tobacco use


subject: CHEBI:60654

subject_name: valproate

object_name: Alzheimer disease type 1


subject: CHEBI:60654

object_name: Alzheimer disease


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026

object_name: Refractory Central Nervous System Lymphoma


subject: CHEBI:4026

object_name: Recurrent Central Nervous System Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: B-cell lymphoma refractory


subject: PUBCHEM.COMPOUND:3368

object_name: B-cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:3368

object_name: Refractory Transformed Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Refractory Transformed B-Cell Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Recurrent Transformed B-Cell Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368

object_name: Marginal zone lymphoma refractory


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: GTOPDB:8966

subject_name: onartuzumab

object_name: non-small cell squamous lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743051

subject_name: ONARTUZUMAB


subject: UMLS:C2826110


subject: UMLS:C5907917

subject_name: Bispecific Antibody QLF3108

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:49863420

subject_name: ceftolozane

object_name: Hospital acquired pneumonia


subject: PUBCHEM.COMPOUND:49863420

object_name: Healthcare associated pneumonia


subject: CHEBI:9421

subject_name: Tazobactam


subject: CHEBI:9421


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: osteoarthritis


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:46195

object_name: Leukemia - chronic myeloid leukemia (CML)


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C1508867

subject_name: MYCOPHENOLIC ACID, ORAL, 180 MG ADMINISTERED

object_name: Rejection acute renal


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:135810

subject_name: Atrasentan

object_name: focal segmental glomerulosclerosis


subject: CHEBI:135810

object_name: Type 2 diabetes mellitus with established diabetic nephropathy


subject: CHEBI:135810

object_name: Alport syndrome


subject: CHEBI:27446

subject_name: Penicillin V

object_name: Wound Infection


subject: CHEBI:27446

object_name: Wound Infection, CTCAE


subject: CHEBI:27446

object_name: cellulitis


subject: CHEBI:27446

object_name: cellulitis on exam (physical finding)


subject: CHEBI:27446

object_name: abscess


subject: CHEBI:9421

object_name: bacteriemia


subject: CHEBI:9421

object_name: Bacteremia, CTCAE


subject: CHEBI:9421

object_name: Enterobacteriaceae Infections


subject: CHEBI:9421

object_name: Beta lactam resistant bacterial infection


subject: UNII:6E01CG547T

subject_name: MITOQUINONE MESYLATE

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C5690695

subject_name: mitoquinone mesylate


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Metastatic Lung Adenocarcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Lung adenocarcinoma recurrent


subject: UNII:DPT0O3T46P


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: UNII:6I3O3W6O3B

subject_name: Entospletinib

object_name: Chronic lymphocytic leukaemia refractory


subject: UNII:6I3O3W6O3B

object_name: B-cell small lymphocytic lymphoma refractory


subject: UNII:6I3O3W6O3B

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UNII:6I3O3W6O3B

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:6I3O3W6O3B

object_name: B-cell prolymphocytic leukemia


subject: UNII:6I3O3W6O3B

object_name: mantle cell lymphoma


subject: UNII:6I3O3W6O3B

object_name: hairy cell leukemia


subject: UNII:6I3O3W6O3B

object_name: lymphoplasmacytic lymphoma


subject: UNII:6I3O3W6O3B

object_name: Waldenstrom macroglobulinemia


subject: UNII:6I3O3W6O3B

object_name: marginal zone lymphoma


subject: UNII:6I3O3W6O3B

object_name: MALT lymphoma


subject: UNII:6I3O3W6O3B

object_name: Lymphoma, Small Cleaved-Cell, Follicular


subject: UNII:6I3O3W6O3B

object_name: Lymphoma, Mixed-Cell, Follicular


subject: UNII:6I3O3W6O3B

object_name: grade 3A follicular lymphoma


subject: UNII:6I3O3W6O3B

object_name: Richter syndrome


subject: UNII:6I3O3W6O3B

object_name: anemia


subject: UNII:6I3O3W6O3B

object_name: Anemia, CTCAE


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UMLS:C5197986

object_name: type 2 diabetes mellitus


subject: UMLS:C5197986

object_name: Diabetes


subject: UMLS:C5197986

object_name: diabetes mellitus


subject: UMLS:C5197986

object_name: type 1 diabetes mellitus 1


subject: UMLS:C5197986

object_name: type 1 diabetes mellitus


subject: CHEBI:9241

subject_name: Spironolactone

object_name: heart disorder


subject: UMLS:C2826358

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42636391

subject_name: Darunavir Ritonavir

object_name: HIV infection


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Friedreich ataxia


subject: CHEBI:44915

subject_name: Propofol

object_name: Anesthesia morbidity


subject: UNII:01KC87F8FE

object_name: AIDS-Related Hodgkin Lymphoma


subject: UNII:01KC87F8FE

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UNII:01KC87F8FE

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:01KC87F8FE

object_name: primary cutaneous B-cell lymphoma


subject: UNII:01KC87F8FE

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:01KC87F8FE


subject: UNII:01KC87F8FE

object_name: Ann Arbor Stage I AIDS-Related Lymphoma


subject: UNII:01KC87F8FE

object_name: Ann Arbor Stage II AIDS-Related Lymphoma


subject: UNII:01KC87F8FE

object_name: Ann Arbor Stage IV AIDS-Related Lymphoma


subject: UNII:01KC87F8FE

object_name: Ann Arbor Stage III AIDS-Related Lymphoma


subject: UNII:01KC87F8FE

object_name: testicular lymphoma


subject: UNII:01KC87F8FE

object_name: AIDS-Related Lymphoblastic Lymphoma


subject: UNII:01KC87F8FE

object_name: intraocular lymphoma


subject: UNII:01KC87F8FE

object_name: Mantle cell lymphoma recurrent


subject: UNII:01KC87F8FE

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UNII:01KC87F8FE

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UNII:01KC87F8FE

object_name: anaplastic large cell lymphoma


subject: UNII:01KC87F8FE

object_name: MALT lymphoma


subject: UNII:01KC87F8FE

object_name: small intestine lymphoma


subject: UNII:01KC87F8FE

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:01KC87F8FE

object_name: hepatosplenic T-cell lymphoma


subject: UNII:01KC87F8FE

object_name: Burkitt lymphoma associated with AIDS


subject: UNII:01KC87F8FE

object_name: AIDS-Related Diffuse Large Cell Lymphoma


subject: UNII:01KC87F8FE

object_name: AIDS-Related Diffuse Mixed Cell Lymphoma


subject: UNII:01KC87F8FE

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UNII:01KC87F8FE

object_name: splenic marginal zone lymphoma


subject: UNII:01KC87F8FE

object_name: nodal marginal zone B-cell lymphoma


subject: UNII:01KC87F8FE

object_name: Marginal zone lymphoma recurrent


subject: UNII:01KC87F8FE

object_name: Immunoblastic lymphoma associated with AIDS


subject: UNII:01KC87F8FE

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: UNII:01KC87F8FE

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UNII:01KC87F8FE

object_name: noncutaneous extranodal lymphoma


subject: UNII:01KC87F8FE

object_name: angioimmunoblastic T-cell lymphoma


subject: UNII:01KC87F8FE

object_name: AIDS-Related Diffuse Small Cleaved Cell Lymphoma


subject: UNII:01KC87F8FE

object_name: Recurrent Adult Burkitt Lymphoma


subject: UNII:01KC87F8FE

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: UNII:01KC87F8FE

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:01KC87F8FE

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: UNII:01KC87F8FE

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UNII:01KC87F8FE

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UNII:01KC87F8FE

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UNII:01KC87F8FE

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UNII:01KC87F8FE

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: UNII:01KC87F8FE

object_name: T-cell large granular lymphocyte leukemia


subject: UNII:01KC87F8FE

object_name: refractory hairy cell leukemia


subject: UNII:01KC87F8FE

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UNII:01KC87F8FE

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:3423

subject_name: Carmustine

object_name: AIDS-Related Hodgkin Lymphoma


subject: CHEBI:3423

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:3423


subject: CHEBI:3423

object_name: Ann Arbor Stage I AIDS-Related Lymphoma


subject: CHEBI:3423

object_name: Ann Arbor Stage II AIDS-Related Lymphoma


subject: CHEBI:3423

object_name: Ann Arbor Stage IV AIDS-Related Lymphoma


subject: CHEBI:3423

object_name: Ann Arbor Stage III AIDS-Related Lymphoma


subject: CHEBI:3423

object_name: AIDS-Related Lymphoblastic Lymphoma


subject: CHEBI:3423

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:3423

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:3423

object_name: anaplastic large cell lymphoma


subject: CHEBI:3423

object_name: small intestine lymphoma


subject: CHEBI:3423

object_name: Burkitt lymphoma associated with AIDS


subject: CHEBI:3423

object_name: AIDS-Related Diffuse Large Cell Lymphoma


subject: CHEBI:3423

object_name: AIDS-Related Diffuse Mixed Cell Lymphoma


subject: CHEBI:3423

object_name: Immunoblastic lymphoma associated with AIDS


subject: CHEBI:3423

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:3423

object_name: AIDS-Related Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:3423

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:3423

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:3423

object_name: refractory hairy cell leukemia


subject: CHEBI:3423

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: AIDS-Related Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: primary cutaneous B-cell lymphoma


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596

object_name: Ann Arbor Stage I AIDS-Related Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Ann Arbor Stage II AIDS-Related Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Ann Arbor Stage IV AIDS-Related Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Ann Arbor Stage III AIDS-Related Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: testicular lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: AIDS-Related Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: intraocular lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Adult Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: MALT lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: small intestine lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: hepatosplenic T-cell lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Burkitt lymphoma associated with AIDS


subject: PUBCHEM.COMPOUND:596

object_name: AIDS-Related Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: AIDS-Related Diffuse Mixed Cell Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: splenic marginal zone lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: nodal marginal zone B-cell lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Immunoblastic lymphoma associated with AIDS


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: noncutaneous extranodal lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: AIDS-Related Diffuse Small Cleaved Cell Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: PUBCHEM.COMPOUND:596

object_name: T-cell large granular lymphocyte leukemia


subject: PUBCHEM.COMPOUND:596

object_name: refractory hairy cell leukemia


subject: PUBCHEM.COMPOUND:596

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:28680

subject_name: Cytarabine

object_name: AIDS-Related Hodgkin Lymphoma


subject: CHEBI:28680

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:28680


subject: CHEBI:28680

object_name: Ann Arbor Stage I AIDS-Related Lymphoma


subject: CHEBI:28680

object_name: Ann Arbor Stage II AIDS-Related Lymphoma


subject: CHEBI:28680

object_name: Ann Arbor Stage IV AIDS-Related Lymphoma


subject: CHEBI:28680

object_name: Ann Arbor Stage III AIDS-Related Lymphoma


subject: CHEBI:28680

object_name: testicular lymphoma


subject: CHEBI:28680

object_name: AIDS-Related Lymphoblastic Lymphoma


subject: CHEBI:28680

object_name: intraocular lymphoma


subject: CHEBI:28680

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:28680

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:28680

object_name: MALT lymphoma


subject: CHEBI:28680

object_name: small intestine lymphoma


subject: CHEBI:28680

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:28680

object_name: Burkitt lymphoma associated with AIDS


subject: CHEBI:28680

object_name: AIDS-Related Diffuse Large Cell Lymphoma


subject: CHEBI:28680

object_name: AIDS-Related Diffuse Mixed Cell Lymphoma


subject: CHEBI:28680

object_name: splenic marginal zone lymphoma


subject: CHEBI:28680

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:28680

object_name: Immunoblastic lymphoma associated with AIDS


subject: CHEBI:28680

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:28680

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:28680

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:28680

object_name: AIDS-Related Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28680

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:28680

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28680

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:28680

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:28680

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:28680

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:28680

object_name: refractory hairy cell leukemia


subject: CHEBI:28680

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:4911

subject_name: Etoposide

object_name: AIDS-Related Hodgkin Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage I AIDS-Related Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage II AIDS-Related Lymphoma


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339

object_name: Ann Arbor Stage IV AIDS-Related Lymphoma


subject: CHEBI:82339

object_name: Ann Arbor Stage III AIDS-Related Lymphoma


subject: CHEBI:82339

object_name: AIDS-Related Lymphoblastic Lymphoma


subject: CHEBI:82339

object_name: small intestine lymphoma


subject: CHEBI:82339

object_name: Burkitt lymphoma associated with AIDS


subject: CHEBI:82339

object_name: AIDS-Related Diffuse Large Cell Lymphoma


subject: CHEBI:82339

object_name: AIDS-Related Diffuse Mixed Cell Lymphoma


subject: CHEBI:82339

object_name: Immunoblastic lymphoma associated with AIDS


subject: CHEBI:82339

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:82339

object_name: AIDS-Related Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: UMLS:C4079909

object_name: heart failure


subject: UMLS:C4079909

object_name: Reduced ejection fraction co-occurrent and due to chronic heart failure


subject: CHEBI:51799

subject_name: Imipenem

object_name: septic shock


subject: CHEBI:190509


subject: CHEMBL.COMPOUND:CHEMBL5314347

subject_name: SEVELAMER CARBONATE

object_name: secondary hyperparathyroidism


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Shoulder pain


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: peripheral nervous system disorder


subject: CHEBI:26710

object_name: neuropathy


subject: CHEBI:26710

object_name: chronic inflammatory demyelinating polyradiculoneuropathy


subject: CHEBI:26710

object_name: Guillain-Barre syndrome, familial


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: UMLS:C0085297


subject: UMLS:C0085297

object_name: diabetes mellitus


subject: UMLS:C2981846

object_name: Adult Meningioma


subject: UMLS:C2981846

object_name: benign meningioma


subject: UMLS:C2981846

object_name: familial meningioma


subject: UMLS:C2981846

object_name: pediatric meningioma


subject: UMLS:C2981846

object_name: meningioma


subject: CHEBI:9927

subject_name: Valsartan

object_name: Crouzon syndrome-acanthosis nigricans syndrome


subject: UMLS:C4688376

subject_name: Anti-CD48/MMAE Antibody-drug Conjugate SGN-CD48A

object_name: plasma cell myeloma


subject: HMDB:HMDB0253804

subject_name: Kisspeptin

object_name: metabolic disease


subject: PUBCHEM.COMPOUND:71306396

subject_name: Kisspeptins


subject: CHEMBL.COMPOUND:CHEMBL4650403

subject_name: KISSPEPTIN


subject: UMLS:C5891187


subject: UMLS:C3146273

subject_name: Metastin


subject: CHEBI:58097

object_name: mucositis


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:92712

subject_name: ENDO-ATROPINE

object_name: Toxic effect of organophosphate and carbamate insecticides


subject: UMLS:C0308371

subject_name: ATROPINE SULPHATE INJECTION


subject: CHEMBL.COMPOUND:CHEMBL2108210

subject_name: LAVENDER OIL

object_name: ankyloglossia


subject: CHEBI:60056

object_name: cocaine use


subject: CHEBI:60056

object_name: Cocaine user


subject: CHEBI:60056

object_name: Hyperthermia


subject: CHEBI:60056

object_name: Fever


subject: CHEBI:27958

subject_name: Cocaine


subject: CHEBI:27958


subject: CHEBI:27958


subject: CHEBI:27958


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: UMLS:C1569697

object_name: pancreatic neoplasm


subject: UMLS:C1569697

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1569697

object_name: malignant pancreatic neoplasm


subject: UMLS:C1569697

object_name: prostate adenocarcinoma


subject: UMLS:C1569697

object_name: non-small cell lung carcinoma


subject: UMLS:C1569697

object_name: colorectal cancer


subject: UMLS:C1569697

object_name: colorectal carcinoma


subject: UMLS:C1569697

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1569697

object_name: Childhood Breast Carcinoma


subject: UMLS:C1569697

object_name: breast carcinoma


subject: UMLS:C1569697

object_name: breast cancer


subject: UMLS:C1569697

object_name: glioma


subject: PUBCHEM.COMPOUND:145705873

subject_name: Chlorotoxin


subject: PUBCHEM.COMPOUND:145705873


subject: PUBCHEM.COMPOUND:145705873


subject: PUBCHEM.COMPOUND:145705873


subject: PUBCHEM.COMPOUND:145705873


subject: PUBCHEM.COMPOUND:145705873


subject: PUBCHEM.COMPOUND:145705873


subject: PUBCHEM.COMPOUND:145705873


subject: PUBCHEM.COMPOUND:145705873


subject: PUBCHEM.COMPOUND:145705873


subject: PUBCHEM.COMPOUND:145705873


subject: PUBCHEM.COMPOUND:145705873

object_name: melanoma


subject: PUBCHEM.COMPOUND:145705873


subject: PUBCHEM.COMPOUND:145705873

object_name: malignant glioma


subject: CHEMBL.COMPOUND:CHEMBL4298122

subject_name: CHLOROTOXIN


subject: CHEMBL.COMPOUND:CHEMBL4298122


subject: CHEMBL.COMPOUND:CHEMBL4298122


subject: CHEMBL.COMPOUND:CHEMBL4298122


subject: CHEMBL.COMPOUND:CHEMBL4298122


subject: CHEMBL.COMPOUND:CHEMBL4298122


subject: CHEMBL.COMPOUND:CHEMBL4298122


subject: CHEMBL.COMPOUND:CHEMBL4298122


subject: CHEMBL.COMPOUND:CHEMBL4298122


subject: CHEMBL.COMPOUND:CHEMBL4298122


subject: CHEMBL.COMPOUND:CHEMBL4298122


subject: CHEMBL.COMPOUND:CHEMBL4298122


subject: CHEMBL.COMPOUND:CHEMBL4298122


subject: CHEMBL.COMPOUND:CHEMBL4298122


subject: UMLS:C0293227


subject: UMLS:C0293227


subject: UMLS:C0293227


subject: UMLS:C0293227


subject: UMLS:C0293227


subject: UMLS:C0293227


subject: UMLS:C0293227


subject: UMLS:C0293227


subject: UMLS:C0293227


subject: UMLS:C0293227


subject: UMLS:C0293227


subject: UMLS:C0293227


subject: UMLS:C0293227


subject: PUBCHEM.COMPOUND:16681698

subject_name: Obatoclax mesylate

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:16681698

object_name: ISS Stage III Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:16681698

object_name: DS Stage III Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:16681698

object_name: DS Stage I Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:16681698

object_name: ISS Stage I Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:16681698

object_name: DS Stage II Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:16681698

object_name: ISS Stage II Plasma Cell Myeloma


subject: CHEBI:94522


subject: CHEBI:94522


subject: CHEBI:94522


subject: CHEBI:94522


subject: CHEBI:94522


subject: CHEBI:94522


subject: CHEBI:94522


subject: UNII:39200FJ43J

subject_name: [OBSOLETE] obatoclax mesylate


subject: UNII:39200FJ43J


subject: UNII:39200FJ43J


subject: UNII:39200FJ43J


subject: UNII:39200FJ43J


subject: UNII:39200FJ43J


subject: UNII:39200FJ43J


subject: UMLS:C1831948

subject_name: obatoclax mesylate


subject: UMLS:C1831948


subject: UMLS:C1831948


subject: UMLS:C1831948


subject: UMLS:C1831948


subject: UMLS:C1831948


subject: UMLS:C1831948


subject: UNII:43HH4XYH2N

subject_name: ENAPOTAMAB VEDOTIN

object_name: Solid Neoplasm


subject: UNII:43HH4XYH2N

object_name: endometrial cancer


subject: UNII:43HH4XYH2N

object_name: uterine corpus cancer


subject: UNII:43HH4XYH2N

object_name: endometrial carcinoma


subject: UNII:43HH4XYH2N

object_name: cervical cancer


subject: UNII:43HH4XYH2N

object_name: cervical carcinoma


subject: UNII:43HH4XYH2N

object_name: ovarian cancer


subject: UNII:43HH4XYH2N

object_name: ovarian neoplasm


subject: UNII:43HH4XYH2N

object_name: ovarian carcinoma


subject: UNII:43HH4XYH2N

object_name: thyroid tumor


subject: UNII:43HH4XYH2N

object_name: thyroid gland carcinoma


subject: UNII:43HH4XYH2N

object_name: thyroid cancer


subject: UNII:43HH4XYH2N

object_name: melanoma


subject: UNII:43HH4XYH2N

object_name: malignant soft tissue neoplasm


subject: UNII:43HH4XYH2N

object_name: sarcoma


subject: UMLS:C4329310

subject_name: HuMax-AXL-ADC


subject: UMLS:C4329310


subject: UMLS:C4329310


subject: UMLS:C4329310


subject: UMLS:C4329310


subject: UMLS:C4329310


subject: UMLS:C4329310


subject: UMLS:C4329310


subject: UMLS:C4329310


subject: UMLS:C4329310


subject: UMLS:C4329310


subject: UMLS:C4329310


subject: UMLS:C4329310


subject: UMLS:C4329310


subject: UMLS:C4329310


subject: CHEBI:52763

object_name: Parkinson disease


subject: CHEBI:188986

subject_name: idose

object_name: neovascular glaucoma


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: alcohol abuse


subject: CHEBI:76016

object_name: alcohol dependence


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: Refractory acute myeloid leukemia


subject: CHEBI:231598

object_name: Recurrent Acute Myeloid Leukemia


subject: MESH:C525703

subject_name: MenACWY

object_name: meningococcal meningitis


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: hyperlipidemia


subject: CHEBI:16347

object_name: hyperlipoproteinemia


subject: CHEBI:16347

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:16347

object_name: Serum lipids high (finding)


subject: CHEBI:28171

object_name: Body Composition


subject: UMLS:C1880230

subject_name: 5-hydroxytryptophan, DL-


subject: CHEBI:17780

subject_name: Oxitriptan


subject: UMLS:C4279586

object_name: Tourette syndrome


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: metastatic colorectal cancer


subject: CHEBI:75998

subject_name: Trametinib


subject: PUBCHEM.COMPOUND:46200932

subject_name: Balovaptan

object_name: Acute Ischemic Stroke


subject: PUBCHEM.COMPOUND:46200932

object_name: Ischemic stroke


subject: UNII:RAX5D5AGV6


subject: UNII:RAX5D5AGV6


subject: UMLS:C5432278

object_name: non-small cell lung carcinoma


subject: CHEBI:32314

subject_name: Geodon

object_name: conduct disorder


subject: CHEBI:32314

object_name: oppositional defiant disorder


subject: CHEBI:10119

subject_name: Ziprasidone


subject: CHEBI:10119


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: Lyme disease


subject: UMLS:C4733431

object_name: liver carcinoma


subject: UMLS:C4733431

object_name: Liver Fibrosis


subject: UMLS:C4733431

object_name: chronic hepatitis B virus infection


subject: CHEBI:35498

subject_name: diuretic

object_name: liver cirrhosis


subject: CHEBI:35498

object_name: Ascites


subject: CHEBI:35498

object_name: Ascites, CTCAE


subject: UMLS:C0012798

subject_name: Diuretics


subject: UMLS:C0012798


subject: UMLS:C0012798


subject: UNII:O880NM097T

subject_name: Avacopan

object_name: vasculitis


subject: UNII:O880NM097T

object_name: Vasculitis, CTCAE


subject: CHEBI:16919

subject_name: Creatine

object_name: myocardial ischemia


subject: CHEBI:16919

object_name: Family history of ischemic heart disease


subject: CHEBI:33942

subject_name: ribose


subject: CHEBI:33942


subject: CHEBI:47013

subject_name: D-ribofuranose


subject: CHEBI:47013


subject: CHEBI:16988

subject_name: D-ribose


subject: CHEBI:16988


subject: CHEBI:18385

subject_name: Thiamine


subject: CHEBI:18385


subject: CHEBI:133021

subject_name: Venetoclax

object_name: B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative


subject: UMLS:C5854690

subject_name: Eviplera

object_name: HIV infection


subject: UMLS:C5907980

subject_name: Topical AKT Inhibitor SM-020

object_name: seborrheic keratosis


subject: CHEBI:50217

subject_name: selegiline

object_name: cognitive disorder


subject: CHEBI:50217


subject: CHEBI:6073

subject_name: Isradipine

object_name: opiate dependence


subject: CHEBI:63717

subject_name: Tenofovir disoproxil

object_name: Substance Use Disorders


subject: PUBCHEM.COMPOUND:5460037

subject_name: isomaltotriose

object_name: keratoconus


subject: PUBCHEM.COMPOUND:5460037

object_name: corneal ectasia


subject: PUBCHEM.COMPOUND:4125253

subject_name: Dextran


subject: PUBCHEM.COMPOUND:4125253


subject: CHEBI:52071

subject_name: dextran


subject: CHEBI:52071


subject: CHEBI:34674

subject_name: dextran sulfate


subject: CHEBI:34674


subject: UMLS:C0751599

subject_name: Betantrone

object_name: Metastatic Cutaneous Melanoma


subject: UMLS:C0751599

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0751599

object_name: metastatic melanoma


subject: UMLS:C0751599

object_name: Melanoma recurrent


subject: CHEBI:6121

subject_name: Ketamine

object_name: psychiatric emergencies


subject: CHEBI:6121

object_name: Dependence on tranquilizers


subject: PUBCHEM.COMPOUND:16138701

subject_name: DiaPep 277

object_name: type 1 diabetes mellitus 1


subject: UNII:F8778UWB0A


subject: UMLS:C0020554

subject_name: Hypertonic Solutions

object_name: bronchiolitis


subject: UMLS:C0022260

subject_name: Isotonic Solutions


subject: CHEBI:34730

subject_name: doxycycline hyclate

object_name: hereditary hemorrhagic telangiectasia


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:56841942

subject_name: Narlaprevir

object_name: chronic hepatitis C virus infection


subject: UMLS:C2974454

subject_name: narlaprevir


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Myeloma-associated amyloidosis


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:229764

subject_name: Selinexor


subject: CHEBI:10650

subject_name: Sumatriptan

object_name: Headache


subject: CHEBI:10650

object_name: Headache, CTCAE


subject: CHEBI:176381

subject_name: Diosmin

object_name: post-thrombotic syndrome


subject: CHEBI:176381

object_name: Postthrombotic Syndrome


subject: CHEBI:176381

object_name: Deep vein thrombosis of lower limb


subject: CHEBI:176381

object_name: Deep venous thrombosis


subject: KEGG.COMPOUND:C00471

subject_name: Plasmin

object_name: Vitreoretinal traction syndrome


subject: UMLS:C0016016

subject_name: plasmin


subject: UMLS:C1135137

object_name: lung cancer


subject: UMLS:C1135137

object_name: lung neoplasm


subject: UMLS:C1135137

object_name: lung carcinoma


subject: CHEBI:3181

subject_name: Bromocriptine

object_name: Insulin Sensitivity


subject: CHEBI:230386

subject_name: Pimonidazole

object_name: Neck Carcinoma


subject: CHEBI:230386

object_name: head and neck neoplasm


subject: CHEBI:230386

object_name: head and neck cancer


subject: UNII:7IK8Z952OK

subject_name: Plecanatide

object_name: irritable bowel syndrome


subject: RXCUI:705860

subject_name: bismuth subcitrate / metronidazole / tetracycline Oral Capsule

object_name: Helicobacter pylori infectious disease


subject: UNII:HS813P8QPX

subject_name: bismuth subcitrate


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline


subject: PUBCHEM.COMPOUND:54685734

subject_name: Epitetracycline


subject: UMLS:C1744619

subject_name: Tetracycline Antibiotics


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:68855

subject_name: Ioflupane I-123

object_name: progressive supranuclear palsy


subject: CHEBI:68855

object_name: Alzheimer disease type 1


subject: CHEBI:68855

object_name: Alzheimer disease


subject: UMLS:C2980484

subject_name: DaTscan


subject: UMLS:C2980484


subject: UMLS:C2980484


subject: UNII:6867Q6IKOD

subject_name: FLORBETAPIR


subject: UMLS:C0114857

subject_name: Dotarem

object_name: kidney disorder


subject: PUBCHEM.COMPOUND:56776542

subject_name: Andecaliximab

object_name: chronic obstructive pulmonary disease


subject: UNII:571045EIM4

subject_name: andecaliximab


subject: UMLS:C3827124


subject: CHEBI:9728

subject_name: Trimethaphan

object_name: type 2 diabetes mellitus


subject: CHEBI:9728

object_name: Insulin resistance


subject: CHEBI:9907

subject_name: ursodiol

object_name: diarrhea


subject: CHEBI:9907

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:9907

object_name: Diarrhea, CTCAE


subject: CHEBI:34435

subject_name: p-Toluenesulfonamide

object_name: non-small cell lung carcinoma


subject: CHEBI:63918

subject_name: Artesunate

object_name: Adherence To Medication Regime


subject: CHEBI:18231

subject_name: arsenic acid


subject: UniProtKB:P0AF61

subject_name: GHOS_ECOLI Endoribonuclease antitoxin GhoS (sprot)


subject: PR:000002156


subject: PR:000006315

subject_name: protein artemis


subject: PR:000003846

subject_name: agouti-related protein


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Abdominal pain


subject: CHEBI:6129

object_name: Abdominal Pain, CTCAE


subject: UMLS:C0486959

subject_name: Human immunodeficiency virus DNA

object_name: HIV-1 infection


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: chronic endometritis


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C0972569

subject_name: Electrophoresis Gel


subject: UMLS:C1382104

subject_name: Gel physical state


subject: UMLS:C1551386

subject_name: Gel - ContainerSeparator


subject: CHEMBL.COMPOUND:CHEMBL5095270

object_name: prostate cancer


subject: CHEMBL.COMPOUND:CHEMBL5095270

object_name: prostate neoplasm


subject: UMLS:C5417962

subject_name: AR Degrader CC-94676


subject: UMLS:C5417962


subject: UMLS:C5553113

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5666891

subject_name: ATI 450


subject: CHEBI:62880

subject_name: Veliparib

object_name: plasma cell myeloma


subject: UMLS:C1831920

subject_name: ABT 888


subject: CHEBI:6078

subject_name: Ivermectin

object_name: Asymptomatic Infections


subject: PUBCHEM.COMPOUND:60918

subject_name: tegaserod

object_name: Chronic constipation


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: sinusitis


subject: CHEBI:63611

object_name: Sinusitis, CTCAE


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Atopic dermatitis and related conditions


subject: UMLS:C3658854


subject: CHEBI:36796

subject_name: duloxetine

object_name: neuropathy, painful


subject: CHEBI:36796

object_name: type 2 diabetes mellitus


subject: CHEBI:36796

object_name: Diabetes


subject: CHEBI:36796

object_name: diabetes mellitus


subject: UNII:Q830PW7520

subject_name: CODEINE

object_name: myopia


subject: PUBCHEM.COMPOUND:2828


subject: CHEBI:57871


subject: CHEBI:16714

subject_name: Codeine


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:72313

subject_name: pasireotide aspartate

object_name: neuroendocrine neoplasm


subject: UMLS:C1136845


subject: CHEBI:6504

object_name: Bone fracture


subject: CHEBI:6504

object_name: Fractured


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: respiratory tract infectious disorder


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:49132

subject_name: FLUDEOXYGLUCOSE

object_name: pancreatic neoplasm


subject: CHEBI:49132

object_name: exocrine pancreatic carcinoma


subject: CHEBI:49132

object_name: malignant pancreatic neoplasm


subject: CHEBI:36939

subject_name: Fluorine F-18


subject: CHEBI:36939


subject: CHEBI:36939


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Physical trauma


subject: CHEBI:74705

object_name: Injury


subject: CHEBI:74705

object_name: Trauma


subject: CHEBI:74705

object_name: traumatic encephalopathy


subject: CHEBI:74705

object_name: traumatic brain injury


subject: CHEBI:74705

object_name: major injury


subject: CHEBI:74705

object_name: Nonpenetrating Wounds


subject: CHEBI:74705

object_name: Wounds, Penetrating


subject: CHEBI:74705

object_name: Multiple Trauma


subject: CHEBI:74705

object_name: Wounds and Injuries


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: CHEMBL.COMPOUND:CHEMBL4754493

object_name: Myelodysplasia


subject: CHEMBL.COMPOUND:CHEMBL4754493

object_name: Adult Myelodysplastic Syndrome


subject: CHEMBL.COMPOUND:CHEMBL4754493

object_name: childhood myelodysplastic syndrome


subject: CHEMBL.COMPOUND:CHEMBL4754493

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL4754493

object_name: acute myeloid leukemia by FAB classification


subject: CHEMBL.COMPOUND:CHEMBL4754493

object_name: acute myeloid leukemia


subject: UNII:L46P54NB4V


subject: UNII:L46P54NB4V


subject: UNII:L46P54NB4V


subject: UNII:L46P54NB4V


subject: UNII:L46P54NB4V


subject: UNII:L46P54NB4V


subject: UMLS:C5239320

subject_name: CK1alpha/CDK7/CDK9 Inhibitor BTX-A51


subject: UMLS:C5239320


subject: UMLS:C5239320


subject: UMLS:C5239320


subject: UMLS:C5239320


subject: UMLS:C5239320


subject: CHEBI:84883

subject_name: Icosapent ethyl

object_name: Dyslipidemia


subject: CHEBI:84883

object_name: inherited lipid metabolism disorder


subject: CHEBI:4670

subject_name: Dobutamine

object_name: tetralogy of fallot


subject: PUBCHEM.COMPOUND:5316

subject_name: Sulbactam

object_name: lung abscess


subject: PUBCHEM.COMPOUND:5316

object_name: pneumonia


subject: PUBCHEM.COMPOUND:5316

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:28971

subject_name: Ampicillin


subject: CHEBI:28971

object_name: peritonitis


subject: CHEBI:28971


subject: CHEBI:28971


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: Small cell lung cancer recurrent


subject: UNII:8M7YSN2KII

object_name: Refractory Lung Small Cell Carcinoma


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:177298

object_name: Recurrent Glioma


subject: CHEBI:177298

object_name: low grade glioma


subject: CHEBI:177298

object_name: IDH2 gene mutation


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: UNII:1S83F4T2WE

subject_name: Mipicoledine

object_name: primary brain neoplasm


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: Acute respiratory tract infection


subject: UMLS:C2348288

object_name: Recurrent acute respiratory tract infection


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: UMLS:C0722654

subject_name: Pletal

object_name: Raynaud disease


subject: CHEBI:31401

subject_name: Cilostazol


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: nasal disorder


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C3896893

object_name: Mechanical ventilation finding


subject: CHEBI:9142

subject_name: Silver sulfadiazine

object_name: Fractured tibia


subject: UNII:08P99TX229

subject_name: firuglipel

object_name: type 2 diabetes mellitus


subject: UMLS:C5198628


subject: CHEBI:61397

subject_name: Neratinib

object_name: Childhood Solid Neoplasm


subject: CHEBI:61397

object_name: Solid Neoplasm


subject: UMLS:C1174389

object_name: prostate carcinoma


subject: UMLS:C1174389

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:24892726

subject_name: Glucomannan

object_name: coronary artery disorder


subject: UMLS:C0260055

subject_name: Liquid nitrogen

object_name: obstructive lung disease


subject: CHEBI:16908

subject_name: NADH

object_name: Inflammation


subject: CHEBI:16908

object_name: Cognitive changes


subject: CHEBI:16908

object_name: neurodegenerative disease


subject: CHEBI:15846

subject_name: NAD(+)


subject: CHEBI:15846


subject: CHEBI:15846


subject: CHEBI:13389

subject_name: Nadide


subject: CHEBI:13389


subject: CHEBI:13389


subject: UMLS:C2370035

subject_name: Keppra XR

object_name: epilepsy


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Human Papillomavirus-Related Anal Squamous Cell Carcinoma


subject: CHEBI:4026

object_name: Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma


subject: CHEBI:4026

object_name: human papillomavirus-related penile squamous cell carcinoma


subject: CHEBI:4026

object_name: Human Papillomavirus-Related Cervical Squamous Cell Carcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UMLS:C5417949

subject_name: Alextatug

object_name: Childhood Breast Carcinoma


subject: UMLS:C5417949

object_name: breast carcinoma


subject: UMLS:C5417949

object_name: breast cancer


subject: UMLS:C5417949

object_name: ovarian cancer


subject: UMLS:C5417949

object_name: ovarian neoplasm


subject: UMLS:C5417949

object_name: ovarian carcinoma


subject: UMLS:C5417949

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: UMLS:C5417949

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: UMLS:C5417949

object_name: colorectal cancer


subject: UMLS:C5417949

object_name: colorectal carcinoma


subject: UMLS:C5417949

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5417949

object_name: triple-negative breast carcinoma


subject: UMLS:C5417949

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5417949

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5417949

object_name: non-small cell lung carcinoma


subject: UMLS:C5417949

object_name: Microsatellite instability-high colorectal cancer


subject: UMLS:C5417949

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5417949

object_name: acral lentiginous melanoma


subject: UMLS:C5417949

object_name: urothelial carcinoma


subject: UMLS:C5417949

object_name: transitional cell carcinoma


subject: UMLS:C5417949

object_name: liver carcinoma


subject: UMLS:C5417949

object_name: melanoma


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: UNII:7DT29059VX

object_name: Childhood Breast Carcinoma


subject: UNII:7DT29059VX

object_name: breast carcinoma


subject: UNII:7DT29059VX

object_name: breast cancer


subject: UNII:7DT29059VX

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: UNII:7DT29059VX

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: UNII:7DT29059VX


subject: UNII:7DT29059VX


subject: UNII:7DT29059VX


subject: UNII:7DT29059VX


subject: UNII:7DT29059VX


subject: UNII:7DT29059VX


subject: UNII:7DT29059VX


subject: UNII:7DT29059VX


subject: CHEBI:39585

subject_name: Carbidopa

object_name: cannabis abuse


subject: CHEBI:39585

object_name: Drug action (disorder)


subject: CHEBI:66964

subject_name: Dronabinol


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: CHEBI:27812

subject_name: Methylselenocysteine


subject: CHEBI:135935

subject_name: Tapentadol

object_name: opioid use


subject: CHEBI:135935

object_name: Visceral Pain


subject: CHEBI:135935

object_name: Analgesics, antipyretics, and antirheumatics causing adverse effects in therapeutic use


subject: CHEBI:135935

object_name: Uterine Pain


subject: CHEBI:3441

subject_name: Carvedilol

object_name: tricuspid valve insufficiency


subject: CHEBI:3441

object_name: Right ventricular dilatation


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin


subject: PUBCHEM.COMPOUND:73151030


subject: UMLS:C0879266

subject_name: Autologous Tumor Cell Vaccine

object_name: renal carcinoma


subject: UMLS:C0879266

object_name: kidney neoplasm


subject: UMLS:C0879266

object_name: kidney cancer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Refractory Diffuse Intrinsic Pontine Glioma


subject: UNII:DPT0O3T46P

object_name: Refractory Ependymoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Diffuse Intrinsic Pontine Glioma


subject: UNII:DPT0O3T46P

object_name: Refractory Medulloblastoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Medulloblastoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Childhood Medulloblastoma


subject: UNII:DPT0O3T46P

object_name: Refractory Brain Neoplasm


subject: UNII:DPT0O3T46P

object_name: Recurrent Childhood Ependymoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Adult Brain Neoplasm


subject: UNII:DPT0O3T46P

object_name: Recurrent Childhood Brain Neoplasm


subject: UNII:DPT0O3T46P

object_name: Recurrent Brain Neoplasm


subject: UNII:DPT0O3T46P

object_name: Constitutional Mismatch Repair Deficiency Syndrome


subject: UNII:DPT0O3T46P

object_name: Lynch syndrome


subject: UNII:DPT0O3T46P

object_name: Hereditary Nonpolyposis Colorectal Cancer


subject: UMLS:C0982054

subject_name: Candida antigen

object_name: Condylomata acuminata in women


subject: UMLS:C0982054

object_name: Genital warts


subject: UMLS:C0982054

object_name: Condylomata acuminata in men


subject: UMLS:C0065828

subject_name: Measles-Mumps-Rubella Vaccine


subject: UMLS:C0065828


subject: UMLS:C0065828


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Hepatocellular Carcinoma by BCLC Stage


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UMLS:C4764320

subject_name: Bupropion HCl Extended Release

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C4764320

object_name: obesity


subject: UMLS:C4764320

object_name: Obesity, CTCAE


subject: UNII:QMH3V8VSPB

object_name: prostate carcinoma


subject: UNII:QMH3V8VSPB

object_name: prostate cancer


subject: UMLS:C1134558

subject_name: Chinese Herbs

object_name: Musculoskeletal Pain


subject: UMLS:C2698398

subject_name: BEMA Fentanyl

object_name: Hypoventilation


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: Unexplained infertility


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: CHEBI:28115

subject_name: Mecobalamin

object_name: vitamin B12 deficiency


subject: CHEBI:28115

object_name: inborn disorder of cobalamin metabolism and transport


subject: UMLS:C0772411

subject_name: potato starch

object_name: bariatric surgery candidate


subject: UMLS:C0392939

subject_name: recombinant human thrombopoietin

object_name: Colorectal cancer recurrent


subject: UNII:NT65DX774J

subject_name: TEBIPENEM PIVOXIL HYDROBROMIDE

object_name: kidney failure


subject: UMLS:C5420943

subject_name: Tebipenem Pivoxil Hydrobromide


subject: UMLS:C1704263

subject_name: green tea extract

object_name: uterine fibroid


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: PR:000007515

subject_name: four and a half LIM domains protein 5

object_name: malignant mesothelioma


subject: PR:000007515

object_name: Malignant pleural effusion


subject: PR:000007515

object_name: Metastatic malignant neoplasm to pleura


subject: PR:000014683


subject: PR:000014683


subject: PR:000014683


subject: PR:000023516

subject_name: pyruvate formate-lyase 1-activating enzyme


subject: PR:000023516


subject: PR:000023516


subject: UniProtKB:P0A9N4

subject_name: PFLA_ECOLI Pyruvate formate-lyase 1-activating enzyme (sprot)


subject: UniProtKB:P0A9N4


subject: UniProtKB:P0A9N4


subject: UMLS:C1550506

subject_name: product - ParticipationType


subject: UMLS:C1550506


subject: UMLS:C1550506


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: Chronic liver disease


subject: UMLS:C3540792

object_name: Avitaminosis


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: CHEBI:15365

subject_name: Aspirin

object_name: Viral pharyngitis


subject: CHEBI:15365

object_name: Sore Throat, CTCAE


subject: CHEBI:15365

object_name: Congestion


subject: CHEBI:15365

object_name: Tissue Congestion


subject: CHEBI:15365

object_name: rhinitis


subject: CHEBI:15365

object_name: Rhinorrhea


subject: CHEBI:15365

object_name: Rhinorrhea, CTCAE


subject: CHEBI:15365

object_name: Sneezing, CTCAE


subject: CHEBI:15365

object_name: Sneeze


subject: CHEBI:15365

object_name: Headache


subject: CHEBI:15365

object_name: Headache, CTCAE


subject: CHEBI:15365

object_name: Malaise, CTCAE


subject: CHEBI:15365

object_name: Malaise


subject: CHEBI:15365

object_name: Fever


subject: CHEBI:15365

object_name: Fever symptoms (finding)


subject: CHEBI:15365

object_name: Fever, CTCAE


subject: CHEBI:15365

object_name: Cough


subject: CHEBI:15365

object_name: Cough, CTCAE


subject: UNII:IZY9ZSI6FI

subject_name: ZILOVERTAMAB VEDOTIN

object_name: urothelial carcinoma


subject: UNII:IZY9ZSI6FI

object_name: transitional cell carcinoma


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4521177

object_name: Mild dementia


subject: UMLS:C4521177

object_name: mild neurocognitive disorder


subject: UMLS:C4055175

subject_name: Curcumin-based Gel

object_name: lichen planus, oral


subject: UMLS:C0723867

subject_name: Triamcinolone Acetonide Topical


subject: CHEBI:84500

subject_name: varenicline

object_name: cancer


subject: CHEBI:84500

object_name: neoplasm


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: benign prostatic hypertrophy with urinary obstruction with other lower urinary tract symptoms


subject: CHEBI:5855

object_name: Benign prostatic hyperplasia with outflow obstruction


subject: CHEBI:94707

subject_name: Benztropine

object_name: psychosis


subject: CHEBI:94707

object_name: schizophreniform disorder


subject: CHEBI:94707

object_name: schizoaffective disorder


subject: CHEBI:94707

object_name: schizophrenia 18


subject: CHEBI:94707

object_name: delusional disorder


subject: CHEBI:3048

subject_name: Benzatropine


subject: CHEBI:3048


subject: CHEBI:3048


subject: CHEBI:3048


subject: CHEBI:3048


subject: PUBCHEM.COMPOUND:122706909

subject_name: Vadastuximab Talirine

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:122706909

object_name: acute myeloid leukemia


subject: UNII:T13V17U431

subject_name: vadastuximab talirine


subject: UNII:T13V17U431


subject: PUBCHEM.COMPOUND:11290583

subject_name: Oxazyme

object_name: Hyperoxaluria


subject: UMLS:C3713930

subject_name: oxazyme


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: Osteosarcoma


subject: PUBCHEM.COMPOUND:44424639

object_name: medulloblastoma


subject: PUBCHEM.COMPOUND:44424639

object_name: Ewing sarcoma


subject: PUBCHEM.COMPOUND:44424639

object_name: connective and soft tissue neoplasm


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743

object_name: breast neoplasm


subject: CHEBI:5050

subject_name: Fexofenadine

object_name: perennial allergic rhinitis


subject: CHEBI:3387

subject_name: Carbamazepine

object_name: Partial Seizure


subject: CHEBI:7824

subject_name: Oxcarbazepine


subject: UMLS:C2987342

object_name: Advanced breast cancer


subject: UMLS:C3640293

subject_name: EphA2-targeting DOPC-encapsulated siRNA

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:135765

subject_name: Methylprednisolone hemisuccinate

object_name: osteoarthritis, knee


subject: CHEBI:35553

subject_name: Perhexiline

object_name: heart failure


subject: CHEBI:7459

subject_name: Naloxone

object_name: angina unstable


subject: CHEBI:3901

subject_name: Tetracosactide

object_name: Post-Dural Puncture Headaches


subject: CHEBI:48390

subject_name: Cinacalcet

object_name: Arterial Stiffness


subject: CHEBI:135949

subject_name: Ambrisentan

object_name: Comorbidity


subject: CHEBI:135949

object_name: cardiovascular disorder


subject: UNII:5L854240DQ

object_name: Solid Neoplasm


subject: UMLS:C5667037

subject_name: Anti-CD20 Antibody-drug Conjugate MRG001

object_name: alcoholic hepatitis


subject: CHEBI:2611

subject_name: Alprazolam

object_name: Food-Drug Interactions


subject: CHEBI:27732

subject_name: Caffeine


subject: UMLS:C0086555

subject_name: licorice


subject: UMLS:C0770612

subject_name: licorice root extract


subject: UMLS:C2728191

subject_name: Licorice


subject: CHEBI:151315

subject_name: Heparin

object_name: osteoarthritis, hip


subject: CHEBI:151315

object_name: familial avascular necrosis of femoral head


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:E47C0NF7LV


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: CHEBI:15354

subject_name: Choline

object_name: liver carcinoma


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: Mycoses


subject: UNII:6GNT3Y5LMF

object_name: acute leukemia of ambiguous lineage


subject: UNII:6GNT3Y5LMF

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UNII:6GNT3Y5LMF

object_name: recurrent childhood acute myeloid leukemia


subject: UNII:6GNT3Y5LMF

object_name: untreated childhood acute myeloid leukemia and other myeloid malignancies


subject: UNII:6GNT3Y5LMF

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: UNII:6GNT3Y5LMF

object_name: Musculoskeletal Complication


subject: UNII:6GNT3Y5LMF

object_name: leukopenia


subject: UNII:6GNT3Y5LMF

object_name: neutropenia


subject: UNII:6GNT3Y5LMF

object_name: diarrhea


subject: UNII:6GNT3Y5LMF

object_name: rectal discharge diarrhea (physical finding)


subject: UNII:6GNT3Y5LMF

object_name: Diarrhea, CTCAE


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:63598


subject: CHEBI:231678

subject_name: Evofosfamide

object_name: carcinoma of esophagus


subject: CHEBI:231678

object_name: esophageal cancer


subject: CHEBI:231678

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:231678

object_name: neoplasm of esophagus


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: CATARACT UNILATERAL PENDING EXTRACTION


subject: CHEBI:8485

subject_name: Proparacaine

object_name: no feeling or sensation of skin


subject: CHEBI:8485

object_name: Sensory Loss


subject: CHEBI:8485


subject: CHEBI:60802

subject_name: ropivacaine


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: lupus erythematosus


subject: CHEBI:31705

subject_name: Iodixanol

object_name: lung cancer


subject: CHEBI:31705

object_name: lung neoplasm


subject: CHEBI:31705

object_name: lung carcinoma


subject: CHEBI:31705

object_name: non-small cell lung carcinoma


subject: CHEBI:31705

object_name: small cell lung carcinoma


subject: CHEBI:31705

object_name: Mesothelioma


subject: CHEBI:31705

object_name: mesothelial neoplasm


subject: CHEBI:31705

object_name: malignant mesothelioma


subject: CHEBI:31709

subject_name: Iohexol


subject: CHEBI:31709


subject: CHEBI:31709


subject: CHEBI:31709


subject: CHEBI:31709


subject: CHEBI:31709


subject: CHEBI:31709


subject: CHEBI:31709


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Port-Wine Stain


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: osteoarthritis


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:94534


subject: CHEBI:94534


subject: MESH:D009822

subject_name: Oils, Volatile

object_name: mental disorder


subject: MESH:D009822

object_name: psychiatric disorder


subject: MESH:D009822

object_name: Benzodiazepine withdrawal


subject: CHEBI:83630

subject_name: essential oil


subject: CHEBI:83630


subject: CHEBI:83630


subject: CHEBI:3215

object_name: Opioid use, unspecified


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine


subject: CHEBI:18145

subject_name: Vitamin E

object_name: immune system disorder


subject: CHEBI:46662

subject_name: mineral


subject: UNII:Q014U50XQH

subject_name: CALCIUM GLYCEROPHOSPHATE

object_name: dental caries


subject: UNII:Q014U50XQH

object_name: Dental Caries, CTCAE


subject: PUBCHEM.COMPOUND:129628127

subject_name: Glycerophosphates


subject: PUBCHEM.COMPOUND:129628127


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: Episodic migraine


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:28593

subject_name: Quinidine


subject: CHEBI:87631

subject_name: statin

object_name: hypertriglyceridemia


subject: CHEBI:87631

object_name: Hypertriglyceridemia, CTCAE


subject: UMLS:C1832032

subject_name: PAR 101

object_name: diarrhea


subject: UMLS:C1832032

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C1832032

object_name: Diarrhea, CTCAE


subject: UMLS:C1832032

object_name: Clostridium infectious disease


subject: MESH:C487655

subject_name: OPT 80


subject: MESH:C110747

subject_name: cyclopropapyrroloindole

object_name: Childhood Breast Carcinoma


subject: MESH:C110747

object_name: breast carcinoma


subject: MESH:C110747

object_name: breast cancer


subject: MESH:C110747

object_name: breast neoplasm


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UMLS:C5222452

subject_name: Insulin Glargine Injection

object_name: type 2 diabetes mellitus


subject: CHEBI:135515

subject_name: Bendamustine

object_name: cold agglutinin disease


subject: CHEBI:135515

object_name: autoimmune hemolytic anemia, cold type


subject: CHEBI:135515

object_name: autoimmune hemolytic anemia


subject: CHEBI:8988

object_name: acute lymphoblastic leukemia


subject: CHEBI:8988

object_name: Hodgkin Disease


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: PUBCHEM.COMPOUND:63020

subject_name: norlestrin

object_name: HIV infection


subject: UMLS:C0126122

subject_name: Loestrin


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Mantle cell lymphoma recurrent


subject: UNII:M89N0Q7EQR

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:M89N0Q7EQR

object_name: nodal marginal zone B-cell lymphoma


subject: UNII:M89N0Q7EQR

object_name: Chronic lymphocytic leukaemia refractory


subject: UNII:M89N0Q7EQR

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:M89N0Q7EQR

object_name: MALT lymphoma


subject: UNII:M89N0Q7EQR

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Marginal zone lymphoma recurrent


subject: UNII:M89N0Q7EQR

object_name: splenic marginal zone lymphoma


subject: UNII:M89N0Q7EQR

object_name: Waldenstrom macroglobulinemia


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PUBCHEM.COMPOUND:4488114

subject_name: Biapenem

object_name: Infection in the elderly


subject: CHEBI:6770

subject_name: MEROPENEM


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: CHEBI:43968

subject_name: Meropenem


subject: UNII:X00B0D5O0E

subject_name: PIPERACILLIN


subject: CHEBI:8232

subject_name: Piperacillin


subject: CHEBI:9421

subject_name: Tazobactam


subject: CHEBI:142708


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: CHEBI:149836

subject_name: Tigecycline


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: musculoskeletal system cancer


subject: CHEBI:94518

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:94518

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:94518

object_name: sarcoma


subject: CHEBI:94518

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:94518

object_name: soft tissue sarcoma


subject: CHEBI:36088

subject_name: thromboxanes A


subject: CHEBI:36088


subject: CHEBI:36088


subject: CHEBI:36088


subject: CHEBI:36088


subject: CHEBI:36088


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: alcohol-related disorders


subject: CHEBI:16796

subject_name: Melatonin


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Charcot's joint of foot


subject: UMLS:C1530450

subject_name: AMG 162


subject: UNII:94W010PZ1Z

object_name: Urinary Urgency


subject: CHEBI:74566

subject_name: Lys-Met

object_name: multidrug-resistant tuberculosis


subject: UMLS:C5774107

subject_name: Km antigen


subject: UMLS:C1709429


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: Charcot-Marie-Tooth disease


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: Calcium deficiency


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: bilateral multicystic dysplastic kidney


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:229764

subject_name: Selinexor

object_name: Neoplasm, Residual


subject: CHEBI:229764


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:50729

subject_name: Mitoxantrone

object_name: lymphoid leukemia


subject: UMLS:C0718247

subject_name: Active brand of pseudoephedrine-triprolidine

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: CHEBI:68564

subject_name: icatibant acetate

object_name: hereditary angioedema


subject: UMLS:C0082926

subject_name: HOE 140


subject: CHEBI:6931

subject_name: Midazolam

object_name: Plexosarcoma


subject: PUBCHEM.COMPOUND:9815560

subject_name: Estreptoquinasa

object_name: acute respiratory distress syndrome


subject: PUBCHEM.COMPOUND:9815560

object_name: adult acute respiratory distress syndrome


subject: PUBCHEM.COMPOUND:9815560

object_name: severe acute respiratory syndrome


subject: UNII:8X1OXL3SNU

subject_name: STREPTOKINASE


subject: UNII:8X1OXL3SNU


subject: UNII:8X1OXL3SNU


subject: UMLS:C0038418

subject_name: streptokinase


subject: UMLS:C0038418


subject: UMLS:C0038418


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]


subject: UMLS:C2825026


subject: CHEBI:151315

subject_name: Heparin


subject: CHEBI:151315


subject: PUBCHEM.COMPOUND:3222

object_name: atrial fibrillation


subject: PUBCHEM.COMPOUND:3222

object_name: Atrial Fibrillation by ECG Finding


subject: PUBCHEM.COMPOUND:3222

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:4784


subject: CHEBI:4784


subject: CHEBI:3380

subject_name: Captopril

object_name: heart failure


subject: CHEBI:3380


subject: CHEBI:3380


subject: CHEBI:3380


subject: UMLS:C0006938

subject_name: captopril


subject: UMLS:C0006938


subject: UMLS:C0006938


subject: UMLS:C0006938


subject: CHEBI:8024

subject_name: Perindopril


subject: CHEBI:8024


subject: CHEBI:8024


subject: CHEBI:8024


subject: CHEBI:6503

subject_name: LISINOPRIL


subject: CHEBI:6503


subject: CHEBI:6503


subject: CHEBI:6503


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: CHEBI:43755


subject: CHEBI:43755


subject: CHEBI:53109

subject_name: Bandrowski's base


subject: CHEBI:53109


subject: CHEBI:53109


subject: CHEBI:53109


subject: PUBCHEM.COMPOUND:157717

subject_name: (R)-METOPROLOL


subject: PUBCHEM.COMPOUND:157717


subject: PUBCHEM.COMPOUND:157717


subject: PUBCHEM.COMPOUND:157717


subject: CHEBI:135117

subject_name: ftivazide

object_name: EXCESS LMW-DNA


subject: CHEBI:6030

subject_name: Isoniazid


subject: UMLS:C3714638

subject_name: Pyridoxine Drug Class


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:16742

subject_name: Orotic acid

object_name: Atopic rhinitis


subject: CHEBI:16742

object_name: Hay fever


subject: CHEBI:22198

subject_name: acetylcysteine

object_name: contrast-induced nephropathy


subject: CHEBI:17561

subject_name: Cysteine


subject: UMLS:C4307736

object_name: cardiovascular disorder


subject: UNII:CZP9GB25HO

object_name: chronic myelomonocytic leukemia


subject: UNII:CZP9GB25HO

object_name: acute myeloid leukemia


subject: UNII:CZP9GB25HO

object_name: Myelodysplasia


subject: UNII:CZP9GB25HO

object_name: Miller-Dieker lissencephaly syndrome


subject: UNII:CZP9GB25HO

object_name: myoclonic dystonia 11


subject: UMLS:C2703182

subject_name: MEK-1/MEKK-1 Inhibitor E6201


subject: UMLS:C2703182


subject: UMLS:C2703182


subject: UMLS:C2703182


subject: UMLS:C2703182


subject: UNII:QMS40680K6

subject_name: Palifermin

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:QMS40680K6

object_name: myelofibrosis


subject: UNII:QMS40680K6

object_name: acute leukemia


subject: CHEBI:8772

subject_name: Raloxifene

object_name: Pulmonary compliance


subject: UNII:04NQ160FRU

subject_name: Strontium ranelate

object_name: postmenopausal osteoporosis


subject: UNII:04NQ160FRU


subject: CHEBI:6801

subject_name: Metformin

object_name: Abdominal obesity


subject: CHEBI:6456

subject_name: Lidocaine

object_name: peripheral nervous system disorder


subject: CHEBI:6456

object_name: neuropathy


subject: CHEBI:6456

object_name: diabetic polyneuropathy


subject: UMLS:C5667055

subject_name: Evalstotug

object_name: melanoma


subject: UMLS:C5667055

object_name: non-small cell lung carcinoma


subject: UMLS:C4033631

subject_name: sacubitril / valsartan

object_name: ST-elevation myocardial infarction


subject: UMLS:C4033631

object_name: ST Elevation Myocardial Infarction


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:9927


subject: UNII:M371870BYL

object_name: hypertension


subject: UNII:M371870BYL

object_name: Hypertension, CTCAE


subject: UMLS:C0125069

subject_name: L-ornithine L-aspartate

object_name: Cirrhosis


subject: CHEBI:3207

subject_name: Budesonide

object_name: esophageal atresia


subject: CHEBI:3207

object_name: Anastomotic stenosis


subject: CHEBI:135515

subject_name: Bendamustine

object_name: refractory malignant neoplasm


subject: CHEBI:135515

object_name: Recurrent Carcinoma


subject: CHEBI:94534

subject_name: olanzapine

object_name: mood disorder


subject: CHEBI:231324

subject_name: alpelisib

object_name: vascular malformation


subject: CHEBI:231324

object_name: PI3K Gene Mutation


subject: CHEBI:231324

object_name: MAP2K1 Gene Mutation


subject: CHEBI:231324

object_name: venous hemangioma


subject: CHEBI:231324

object_name: Venous malformation


subject: CHEBI:231324

object_name: Congenital lymphatic malformation


subject: CHEBI:231324

object_name: Venous malformation, low flow


subject: CHEBI:231324

object_name: arteriovenous hemangioma/malformation


subject: CHEBI:231324

object_name: Lymphatic malformation, low flow


subject: CHEBI:231324

object_name: congenital vascular malformation


subject: CHEBI:231324

object_name: vascular anomaly


subject: CHEBI:231324

object_name: PIK3CA-related overgrowth spectrum


subject: CHEBI:231324

object_name: cystic hygroma


subject: CHEBI:231324

object_name: lymphangioma


subject: CHEBI:231324

object_name: Rare lymphatic malformation


subject: CHEBI:231324


subject: CHEBI:88249

subject_name: Mirdametinib


subject: CHEBI:88249

object_name: PIK3CA Gene Mutation


subject: CHEBI:88249


subject: CHEBI:88249


subject: CHEBI:88249


subject: CHEBI:88249

object_name: lymphatic malformation


subject: CHEBI:88249


subject: CHEBI:88249


subject: CHEBI:88249


subject: CHEBI:88249


subject: CHEBI:88249


subject: CHEBI:88249


subject: CHEBI:88249


subject: CHEBI:88249


subject: CHEBI:88249


subject: CHEBI:88249


subject: CHEBI:88249


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Depressed mood


subject: CHEBI:38545

object_name: Cancer patients and suicide and depression


subject: CHEBI:38545

object_name: Depressed - symptom


subject: CHEBI:38545

object_name: Depression, CTCAE


subject: CHEBI:15367

subject_name: Tretinoin

object_name: Premalignant Lesion


subject: CHEBI:15367

object_name: oral cavity carcinoma


subject: CHEBI:15367

object_name: oral cavity cancer